Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1

This study provides evidence that hypoxia mediates TMZ resistance in GBM through the HIF-1α/PRMT6/G3BP1 axis, identifying PRMT6 and G3BP1 as promising therapeutic targets to overcome chemoresistance.

Authors

Institutions

Publication Details

Journal
Journal of Translational Medicine
Published
2026-01-02
DOI
https://doi.org/10.1186/s12967-025-07618-5
Primary Topic
Cancer-related gene regulation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1

S S Chen, Guangyu Li, Peng Yu, Boxiang Zhang et al.
Journal of Translational Medicine
Cancer-related gene regulation
article

Hypoxia-induced PRMT6 expression promotes temozolomide chemoresistance in glioblastoma via G3BP1

S S Chen, Guangyu Li, Peng Yu, Boxiang Zhang, Yuting Yan, Yongqing Sun
article en

Abstract

This study provides evidence that hypoxia mediates TMZ resistance in GBM through the HIF-1α/PRMT6/G3BP1 axis, identifying PRMT6 and G3BP1 as promising therapeutic targets to overcome chemoresistance.

Journal of Translational MedicineVol. 24(1)
First Hospital of China Medical University (CN), China Medical University (CN)
Openalex Percentile: Top 98%
Cancer-related gene regulation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.